A new weapon for resistant bacteria

Credit: © EYE OF SCIENCE / PHOTO RESEARCHERS, INC" /> Credit: © EYE OF SCIENCE / PHOTO RESEARCHERS, INC Methicillin-resistant Staphylococcus aureus (MRSA), a longtime bane of hospitals, thwarts the antibiotic by integrating a mobile genetic element, staphylococcal cassette chromosome mec (SCCmec). More than 10 years ago, Keiichi Hiramatsu's group at Juntendo University in Tokyo started to notice variations of SCCmec, with different combinations of recombinases to transfer the el

Written byIshani Ganguli
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Methicillin-resistant Staphylococcus aureus (MRSA), a longtime bane of hospitals, thwarts the antibiotic by integrating a mobile genetic element, staphylococcal cassette chromosome mec (SCCmec). More than 10 years ago, Keiichi Hiramatsu's group at Juntendo University in Tokyo started to notice variations of SCCmec, with different combinations of recombinases to transfer the element and one or more resistance genes.

In a 2004 paper, the researchers found a fifth variation of SCCmec - the second to arise outside hospital walls - among Australian aboriginals.1 Unlike the previous four versions described, type V has only one recombinase, ccrC, which is surprisingly sufficient for integration, says first author Teruyo Ito. Smaller than the other four, and containing genes for a restriction-modification system, SCCmec V is more stably integrated, says Hiramatsu.

Such classifications help scientists and clinicians understand the evolution of resistance. While types already identified account for 90% of MRSA strains found globally, Hiramatsu says ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies